SAP30通过桥接转录核心压缩器SIN3复合体和MLL1促进乳腺瘤的进展
Lei Bao1, Ashwani Kumar2, Ming Zhu1
1Department of Pathology.
The Journal of clinical investigation
|September 1, 2023
概括
乳腺瘤中的一种蛋白质SAP30,作为促进癌症生长和转移的瘤蛋白. 它增强了基因活性,与其典型的沉默作用不同,揭示了乳腺癌的新治疗点.
科学领域:
- 分子生物学分子生物学
- 在瘤学瘤学.
- 基因规则 基因规则
背景情况:
- SAP30是SIN3转录复合体的一个核心子单元.
- 它在基因调节和人类癌症中的特定作用仍然在很大程度上是未知的.
研究的目的:
- 研究SAP30在乳腺癌发育和进展中的作用.
- 阐明SAP30在瘤生长中的作用背后的分子机制.
主要方法:
- 在人类乳腺瘤中分析SAP30表达.
- 利用乳腺癌小鼠模型研究SAP30功能.
- 研究了SAP30与SIN3A/3B和MLL1.1的相互作用.
- 评估了对染色质可访问性和RNA聚合酶II占用量的影响.
主要成果:
- 在超过50%的人类乳腺瘤中,SAP30的上调,与患者的不良结果相关.
- 在小鼠模型中,SAP30促进瘤生长和转移,独立于其正规基因沉默功能.
- SAP30作为一个协活性剂,增强染色质的可访问性和RNA聚合酶II在促进剂.
- SAP30招募MLL1,这对其同活化和瘤进展至关重要.
- SAP30形成一个同位素,其中一个子单位结合SIN3A,另一个招募MLL1.1.
结论:
- 在乳腺癌中,SAP30作为一种非突变性上蛋白.
- SAP30通过协同激活参与运动性,血管生成和淋巴血管生成的基因来驱动瘤的进展.
- SAP30代表了乳腺癌中一种新的转录依赖性,突出了其作为治疗点的潜力.
相关概念视频
02:23Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
01:22PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
01:19Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
01:07MAPK Signaling Cascades
5.6K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.6K
02:07Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K